BioNTech SE (NASDAQ:BNTX) ranks among the best high growth European stocks to buy. On January 16, Goldman Sachs upgraded ...

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

Company showcases military housing as foundation for readiness and national security defense Corvias, a trusted infrastructure and resiliency partner to the U.S. military and higher education ...

– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end – – ...

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs) ...

TAMPA, Fla. and LONDON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates (ADCs), today ...

TAMPA, Fla. and LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today ...

Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment by combining the selectivity of monoclonal antibodies with the potency of cytotoxic drugs. However, the unique ...

Detailed price information for Agree Realty Corp (ADC-N) from The Globe and Mail including charting and trades.

MONTEREY, Calif.--(BUSINESS WIRE)--Corvias, a trusted infrastructure and resiliency partner to the U.S. military and higher education institutions, spoke on key defense community priorities in an ...